‘Absolutely remarkable’ : No one who got Moderna’s vaccine in trial developed severe COVID-19
Biotech will ask FDA for emergency approval as final results from efficacy trial back up initial claim of vaccine success.
Related Articles
U.S. government in hot seat for response to growing cow flu outbreak
Veterinarians and researchers on the front lines say it has taken too long to share data on viral changes, spread, and milk safety
Forced to eat bat feces, chimps could spread deadly viruses to humans
Tobacco farming is driving apes to seek unusual food source, brimming with pathogens
Where did Earth’s oddball ‘quasi-moon’ come from? Scientists pinpoint famed lunar crater
Impact that created the asteroid also blasted out the famous Giordano Bruno crater
Should researchers use AI to write papers? Group aims for community-driven standards
Tools such as ChatGPT may be used for 1% to 5% of manuscripts, recent estimates suggest
Scientists repot flowering plants’ tree of life—and find it has tangled roots
The most comprehensive look at genetic differences among flowering plants suggests ancient interbreeding confounded relationships between dogwoods and blueberries, among others
‘Tag!’ Other great apes share our affinity for playful teasing
Surprisingly similar teasing behaviors across species suggest it evolved at least 13 million years ago
When does life end? New organ donation strategy fuels debate
A new procedure for donating hearts and other organs is saving lives. But for some it challenges the definition of death
Embattled Harvard honesty professor accused of plagiarism
Academic chapter and two books authored by Francesca Gino appear to copy from sources including student theses, blogs, and news reports
NIH boosts pay for postdocs and graduate students
The increases are welcome news, but fall short of an advisory group’s recommendation
Universities should experiment to improve caregiver support, U.S. National Academies says
New report recommends paid leave, flexible work policies, and changes in academic culture